We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

Dr. Kam Shojania, MD FRCPC, Rheumatologist, discusses osteoporosis management. Samuel Alito Comment During Obamacare Supreme ...

Denosumab plus romosozumab vs denosumab only was associated with improved bone mineral density among patients with severe ...

Health care professionals should assess baseline bone mineral density in patients with osteoporosis before determining ...

That means that if you aren’t currently doing anything to preserve your bones, your risk for osteoporosis is increasing.

To ensure your safety during exercise for osteoporosis, keep these guidelines in mind: - Talk to your doctor before beginning any exercise program. This is especially important if you know you ...

Romosozumab vs bisphosphonate use was not linked to increased CVD risks among patients with osteoporosis, challenging past concerns over its cardiovascular safety.

Osteoporosis can be defined as a condition in which the quality of the structure of bones changes when bone mineral density ...

Her work informed updated NICE osteoporosis guidelines and was published in esteemed medical journals, including The Lancet. Mr Davies recorded an inquest conclusion of 'road traffic collision', ...

Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Her work informed updated NICE osteoporosis guidelines and was published in esteemed medical journals, including The Lancet. Mr Davies recorded an inquest conclusion of 'road traffic collision ...

In addition, patients should be prescribed a bisphosphonate, according to the 2002 Canadian osteoporosis guidelines [11] (since they will require greater than 3 months of at least 7.5 mg ...